PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML

Main information

  • Trade name:
  • PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML SOLUTION
  • Dosage:
  • 4MG
  • Pharmaceutical form:
  • SOLUTION
  • Composition:
  • DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE) 4MG
  • Administration route:
  • INTRA-ARTICULAR
  • Units in package:
  • 5 X 5ML
  • Prescription type:
  • Prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML SOLUTION
    Canada
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • ADRENALS
  • Product summary:
  • Active ingredient group (AIG) number: 0106305003; AHFS: 68:04.00

Other information

Status

  • Source:
  • Health Canada
  • Authorization status:
  • MARKETED
  • Authorization number:
  • 00751863
  • Authorization date:
  • 31-12-1989
  • Last update:
  • 27-11-2018

There are no safety alerts related to this product.

2-8-2018

EU/3/18/2047 (Glycomine SARL)

EU/3/18/2047 (Glycomine SARL)

EU/3/18/2047 (Active substance: Liposomal mannose-1-phosphate) - Orphan designation - Commission Decision (2018)5279 of Thu, 02 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/055/18

Europe -DG Health and Food Safety